Drug intelligence / Profile preview

Ojowin

Development stage: Unknown
Lead developer: Chaitanya Pharmaceuticals
Administration: Oral

Overview

Ojowin is a proprietary Ayurvedic herbal formulation manufactured by Chaitanya Pharmaceuticals in Nasik, India. Supplied as a 500 mg tablet, it is traditionally used as an immunomodulator, antioxidant, anti-aging agent, aphrodisiac, antitumor agent, and adaptogen. It is designed to support overall vitality, enhance immune function, and promote healthy aging through the synergistic action of its herbal ingredients.

Brand names: Ojowin
Other names: Ojowin TabletTab. Ojowin

Beyond the preview

Go deeper on Ojowin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ojowin.

Explore the full profile